Arrowhead Pharmaceuticals Inc. (ARWR) Appoints Hongbo Lu to its Board
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Join SI Premium – FREE
On February 21, 2024, the Board of Directors of Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) announced that it would increase the size of the Company's board of directors ("Board") from seven to eight members and appoint Hongbo Lu, Ph.D., as an independent director of the Company, effective April 1, 2024.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Space-Eyes names four directors ahead of planned Nasdaq listing
- Splash Beverage Group rebrands as Endovia Health Sciences on NYSE American
- Robo.ai names Hao Wang of Changer.ae to its board of directors
Create E-mail Alert Related Categories
8K, Board Changes, Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
